| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 75644-90-5 | L-Threonine,L-tyrosyl-D-serylglycyl-L-phenylalanyl-L-leucyl-; L-Threonine,N-[N-[N-[N-(N-L-tyrosyl-D-seryl)glycyl]-L-phenylalanyl]-L-leucyl]-; 160: PN:US20030176421 PAGE: 54-55 claimed protein; H-Tyr-D-Ser-Gly-Phe-Leu-Thr; Tyr-D-Ser-Gly-Phe-Leu-Thr; Tyr-D-Ser-Gly-Phe-Leu-Thr-OH; [D-Ser2-Leu5-Thr6]enkephalin; [D-Ser2-Leu5]enkephalin-Thr6 |  | C33H46N6O10 | 詳情 | 供應商 | |
| 532932-99-3 | ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-IL | (ALA11,D-LEU15)-OREXIN B (HUMAN); ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-ILE-Leu-Thr-MET-NH2; H-ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-ILE-Leu-Thr-MET-NH2; [ALA11,D-LEU15]-OREXIN B; (ALA11,D-LEU15)-OREXIN B (HUMAN); H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Ala-Gln-Arg-Leu-D-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2; M.W. 2857.28 C120H206N44O35S |  | C120H206N44O35S | 詳情 | 供應商 |
| 114547-31-8 | GALANIN (RAT) | GALANIN, RAT; GWTLNSAGYLLGPHAIDNHRSFSDKHGLT-NH2; GLY-TRP-THR-LEU-ASN-SER-ALA-GLY-TYR-LEU-LEU-GLY-PRO-HIS-ALA-ILE-ASP-ASN-HIS-ARG-SER-PHE-SER-ASP-LYS-HIS-GLY-Leu-Thr-NH2; H-GLY-TRP-THR-LEU-ASN-SER-ALA-GLY-TYR-LEU-LEU-GLY-PRO-HIS-ALA-ILE-ASP-ASN-HIS-ARG-SER-PHE-SER-ASP-LYS-HIS-GLY-Leu-Thr-NH2; GALANIN, RAT; Galanin(1-29)(rat,mouse); Galanine(1-29)【rat】; Galanine【rat】 |  | C141H211N43O41 | 詳情 | 供應商 |
| 119418-04-1 | GALANIN (HUMAN) | GALANIN, HUMAN; H-GLY-TRP-THR-LEU-ASN-SER-ALA-GLY-TYR-LEU-LEU-GLY-PRO-HIS-ALA-VAL-GLY-ASN-HIS-ARG-SER-PHE-SER-ASP-LYS-ASN-GLY-Leu-Thr-SER-OH; GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS; GLY-TRP-THR-LEU-ASN-SER-ALA-GLY-TYR-LEU-LEU-GLY-PRO-HIS-ALA-VAL-GLY-ASN-HIS-ARG-SER-PHE-SER-ASP-LYS-ASN-GLY-Leu-Thr-SER; GALANIN, HUMAN; GALANIN (1-30) (HUMAN); Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu-Thr-Ser; M.W. 3157.41 C139H210N42O43 |  | C139H210N42O43 | 詳情 | 供應商 |
| 205640-91-1 | 食欲肽B (人) | OREXIN B (HUMAN); ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-LEU-GLN-ARG-LEU-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-ILE-Leu-Thr-MET-NH2; HYPOCRETIN-2; HYPOCRETIN-2, HUMAN; H-ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-LEU-GLN-ARG-LEU-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-ILE-Leu-Thr-MET-NH2; RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2; OREXINS OREXIN B HUMAN; OREXIN B (HUMAN); H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 |  | C123H212N44O35S | 詳情 | 供應商 |
| 205640-90-0 | OREXIN A (HUMAN, BOVINE, CANINE, MOUSE, OVINE, PORCINE, RAT) | PYR-PRO-LEU-PRO-ASP-CYS-CYS-ARG-GLN-LYS-THR-CYS-SER-CYS-ARG-LEU-TYR-GLU-LEU-LEU-HIS-GLY-ALA-GLY-ASN-; HYPOCRETIN; PYR-PRO-LEU-PRO-ASP-CYS-CYS-ARG-GLN-LYS-THR-CYS-SER-CYS-ARG-LEU-TYR-GLU-LEU-LEU-HIS-GLY-ALA-GLY-ASN-HIS-ALA-ALA-GLY-ILE-Leu-Thr-LEU-NH2; PYR-PRO-LEU-PRO-ASP-CYS-CYS-ARG-GLN-LYS-THR-CYS-SER-CYS-ARG-LEU-TYR-GLU-LEU-LEU-HIS-GLY-ALA-GLY-ASN-HIS-ALA-ALA-GLY-ILE-Leu-Thr-LEU-NH2 (DISULFIDE BRIDGE: 6-12 AND 7-14); PYR-PLPDCCRQKTCSCRLYELLHAGAGNHAAGILTL-NH2; PYR-PLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2; PYR-PLPDCCRQKTCSCRLYELLHGAGNHAAGILTL-NH2 (DISULFIDE BRIDGE: 6-12 AND 7-14); OREXINS OREXIN A HUMAN, RAT, MOUSE; OREXIN A, BOVINE, HUMAN, MOUSE, RAT |  | C152H247N47O44S4 | 詳情 | 供應商 |
| 59763-91-6 | PANCREATIC POLYPEPTIDE, HUMAN; PANCREATIC POLYPEPTIDE; PANCREATIC POLYPEPTIDE, HUMAN; PP, HUMAN; APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2; H-ALA-PRO-LEU-GLU-PRO-VAL-TYR-PRO-GLY-ASP-ASN-ALA-THR-PRO-GLU-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-LEU-ARG-ARG-TYR-ILE-ASN-MET-Leu-Thr-ARG-PRO-ARG-TYR-NH2; ALA-PRO-LEU-GLU-PRO-VAL-TYR-PRO-GLY-ASP-ASN-ALA-THR-PRO-GLU-GLN-MET-ALA-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-LEU-ARG-ARG-TYR-ILE-ASN-MET-Leu-Thr-ARG-PRO-ARG-TYR-NH2; ALA-PRO-LEU-GLU-PRO-VAL-TYR-PRO-GLY-ASP-ASN-ALA-THR-PRO-GLU-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-LEU-ARG-ARG-TYR-ILE-ASN-MET-Leu-Thr-ARG-PRO-ARG-TYR-NH2; ALA-PRO-LEU-GLU-PRO-VAL-TYR-PRO-GLY-ASP-ASN-ALA-THR-PRO-GLU-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-LEU-ARG-ARG-TYR-ILE-ASN-MET-Leu-Thr-ARG-PRO-ARG-TYR-NH2 HUMAN |  | C185H287N53O54S2 | 詳情 | 供應商 | |
| 75976-10-2 | 人體胰臟多肽 | PANCREATIC POLYPEPTIDE, HUMAN; H-ALA-PRO-LEU-GLU-PRO-VAL-TYR-PRO-GLY-ASP-ASN-ALA-THR-PRO-GLU-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-LEU-ARG-ARG-TYR-ILE-ASN-MET-Leu-Thr-ARG-PRO-ARG-TYR-NH2; APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2; ALA-PRO-LEU-GLU-PRO-VAL-TYR-PRO-GLY-ASP-ASN-ALA-THR-PRO-GLU-GLN-MET-ALA-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-LEU-ARG-ARG-TYR-ILE-ASN-MET-Leu-Thr-ARG-PRO-ARG-TYR-NH2; ALA-PRO-LEU-GLU-PRO-VAL-TYR-PRO-GLY-ASP-ASN-ALA-THR-PRO-GLU-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-LEU-ARG-ARG-TYR-ILE-ASN-MET-Leu-Thr-ARG-PRO-ARG-TYR-NH2; ALA-PRO-LEU-GLU-PRO-VAL-TYR-PRO-GLY-ASP-ASN-ALA-THR-PRO-GLU-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-LEU-ARG-ARG-TYR-ILE-ASN-MET-Leu-Thr-ARG-PRO-ARG-TYR-NH2 HUMAN; PP, HUMAN; PANCREATIC POLYPEPTIDE; PANCREATIC POLYPEPTIDE, HUMAN |  | C185H287N53O54S2 | 詳情 | 供應商 |
| 90419-12-8 | ALA-PRO-LEU-GLU-PRO-MET-TYR-PRO-GLY-ASP-TYR-ALA-THR-HIS-GLU-GLN-ARG-ALA-GLN-TYR-GLU-THR-GLN-LEU-ARG- | PANCREATIC POLYPEPTIDE, RAT; APLEPMYPGDYATHEQRAQYETQLRRYINTLTRPRY-NH2; H-ALA-PRO-LEU-GLU-PRO-MET-TYR-PRO-GLY-ASP-TYR-ALA-THR-HIS-GLU-GLN-ARG-ALA-GLN-TYR-GLU-THR-GLN-LEU-ARG-ARG-TYR-ILE-ASN-THR-Leu-Thr-ARG-PRO-ARG-TYR-NH2; ALA-PRO-LEU-GLU-PRO-MET-TYR-PRO-GLY-ASP-TYR-ALA-THR-HIS-GLU-GLN-ARG-ALA-GLN-TYR; ALA-PRO-LEU-GLU-PRO-MET-TYR-PRO-GLY-ASP-TYR-ALA-THR-HIS-GLU-GLN-ARG-ALA-GLN-TYR-GLU-THR-GLN-LEU-ARG-ARG-TYR-ILE-ASN-THR-Leu-Thr-ARG-PRO-ARG-TYR-NH2; PANCREATIC POLYPEPTIDE, RAT; PP, RAT; Ala-Pro-Leu-Glu-Pro-Met-Tyr-Pro-Gly-Asp-Tyr-Ala-Thr-Ala-Thr-His-Glu-Gln-Arg-Ala-Gln-Tyr-Glu-Thr-Gln-Leu-Arg-Arg-Tyr-Ile-Asn-Thr-Leu-Thr-Arg-Tyr-NH2; ala-pro-leu-glu-pro-met-tyr-pro-gly-asp-tyr-ala-thr-his-glu-gln-arg-ala-gln-tyr-glu-thr-gln-leu-arg-arg-tyr-ile-asn-thr-Leu-Thr-arg-pro-arg-tyr-nh2 |  | C195H298N58O57S1 | 詳情 | 供應商 |